Stock Report

Download full stock data and analysis for free Last Updated: 15-Oct-2026

Stock Rating

Is this stock worth it? Our ratings reveal the truth.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

Sanofi Consumer Healthcare India Peer Comparison

Stock Card factsheet watchlist-stock-modal share-fund-plan-icon

NSE: SANOFICONR | BSE: 544250

₹3,573.30

up-down-arrow ₹-40.90 (-1.13%)

As on 15-Oct-2026IST

Market cap

info icon

₹8,268 Cr

Revenue (TTM)

info icon

₹950 Cr

P/E Ratio

info icon

31.1

P/B Ratio

info icon

23.8

Div. Yield

info icon

2.1 %

Edit peer-selector-edit
Sanofi Consumer Healthcare India Marksans Pharma Sai Life Sciences Indegene Dishman Carbogen
Market cap (₹ Cr)
 8,268 13,957 29,654 14,277 2,372
Revenue (₹ Cr)
 950 3,172 2,250 3,813 2,901
Net Profit (₹ Cr)
 266.00 521.27 361.74 400.90 16.16
Net Margin (%)
 27.44 15.92 15.77 10.30 0.55
RoE (%)
 72.69 18.10 15.47 13.87 0.29
Price to Earnings
 31.08 27.01 81.98 35.61 146.79
Price-To-Book
 23.76 4.39 11.61 4.45 0.36

Income Statement (₹ Cr)

Sanofi Consumer Healthcare India Marksans Pharma Sai Life Sciences Indegene Dishman Carbogen
Operating Revenue arrow
949.80 3,171.75 2,250.36 3,812.80 2,901.49
Total Income arrow
969.30 3,274.04 2,293.13 3,891.70 2,950.84
Total Expenditure arrow
596.90 2,458.06 1,592.13 3,174.90 2,416.46
EBITDA arrow
352.90 713.69 658.23 637.90 485.03
Depreciation arrow
13.20 100.39 175.07 148.90 348.02
EBIT arrow
339.70 613.30 483.16 489.00 137.01
Interest arrow
2.00 25.06 34.51 22.00 168.51
Other Income arrow
19.50 102.29 42.77 78.90 49.35
Exceptional Items arrow
0.00 0.00 -8.00 -20.30 -2.84
Profit before Tax arrow
357.20 690.53 483.42 525.60 15.01
Provision for Tax arrow
91.20 169.26 121.68 124.70 -1.15
Profit after Tax arrow
266.00 521.27 361.74 400.90 16.16

Liabilities (₹ Cr)

Sanofi Consumer Healthcare India Marksans Pharma Sai Life Sciences Indegene Dishman Carbogen
Shareholder's Funds arrow
347.90 3,023.16 2,483.69 3,138.70 6,676.90
Minority Interest arrow
0.00 -4.52 0.00 0.00 0.00
Non-Current Liabilities arrow
31.40 281.13 308.77 395.40 2,929.36
Current Liabilities arrow
327.10 527.09 833.68 1,086.20 2,317.05
Total Liabilities arrow
750.80 3,239.63 3,209.12 3,325.90 9,986.90

Assets (₹ Cr)

Sanofi Consumer Healthcare India Marksans Pharma Sai Life Sciences Indegene Dishman Carbogen
Non-Current Assets arrow
22.50 814.79 1,827.93 1,764.80 8,580.12
Current Assets arrow
663.40 2,722.74 1,410.53 2,618.40 2,842.10
Total Assets arrow
750.80 3,239.63 3,209.12 3,325.90 9,986.90
Total Debt* arrow
0.00 23.09 128.64 0.00 2,083.91
Net Current Assets arrow
336.30 2,195.65 576.85 1,532.20 525.05
Contingent Liabilities arrow
1.50 -- 58.11 -- 423.42

Cashflow (₹ Cr)

Sanofi Consumer Healthcare India Marksans Pharma Sai Life Sciences Indegene Dishman Carbogen
Cash From Operating Activities arrow
174.80 206.66 314.05 441.90 371.28
Cash Flow from Investing Activities arrow
7.60 -49.01 -536.67 -682.70 -192.21
Cash from Financing Activities arrow
-134.50 -65.15 301.43 287.50 -102.09
Net Cash Inflow / Outflow arrow
47.90 92.51 78.81 46.70 76.98

Ratios

Profitability Ratios

 Sanofi Consumer Healthcare India Marksans Pharma Sai Life Sciences Indegene Dishman Carbogen
ROCE (%) arrow
98.11 22.50 15.53 25.24 2.31
ROE (%) arrow
72.69 18.10 15.47 13.87 0.29
ROA (%) arrow
47.15 14.68 10.66 10.09 0.15
EBIT Margin (%) arrow
35.77 19.34 21.47 12.83 4.72
Net Margin (%) arrow
27.44 15.92 15.77 10.30 0.55
Cash Profit Margin (%) arrow
0.00 0.00 0.00 0.00 0.00

Growth Ratios

 Sanofi Consumer Healthcare India Marksans Pharma Sai Life Sciences Indegene Dishman Carbogen
Revenue Growth (%) arrow
31.17 19.59 17.74 30.41 0.20
EBIT Growth (%) arrow
34.86 46.61 36.01 2.09 -50.39
Net Profit Growth (%) arrow
33.00 48.19 48.20 -7.92 -84.49
EPS Growth (%) arrow
34.44 47.58 48.53 -4.75 -85.24
Book Value Growth (%) arrow
41.18 19.46 120.22 84.55 3.63

Valuation Ratios

 Sanofi Consumer Healthcare India Marksans Pharma Sai Life Sciences Indegene Dishman Carbogen
Price / Earnings arrow
31.08 27.01 80.18 34.24 127.45
Price / Book Value arrow
23.76 4.39 11.61 4.45 0.36
Dividend Yield (%) arrow
2.09 0.29 0.00 0.38 0.00
EV/EBITDA arrow
22.36 18.21 44.96 20.06 8.54
Market Cap (₹ Cr) arrow
10,410.62 10,075.92 15,882.87 13,848.97 3,411.88

Solvency Ratios

 Sanofi Consumer Healthcare India Marksans Pharma Sai Life Sciences Indegene Dishman Carbogen
Debt to Equity arrow
0.00 0.00 0.01 0.00 0.23
Short term debt to equity ratio arrow
-- 0.01 0.06 -- 0.11
Current Ratio arrow
2.03 5.17 1.69 2.41 1.23
Quick Ratio arrow
1.74 3.32 1.51 2.41 0.79
Interest Coverage arrow
179.60 28.55 15.01 24.89 1.09

Operating Efficiency Ratios

 Sanofi Consumer Healthcare India Marksans Pharma Sai Life Sciences Indegene Dishman Carbogen
Debtors to sales (%) arrow
5.24 20.32 16.60 25.75 23.19
Asset Turnover arrow
1.68 0.89 0.66 0.96 0.26
Receivable days arrow
8.58 65.99 65.73 89.95 77.38
Inventory Days arrow
20.38 97.24 22.19 0.00 120.02
Payable days arrow
118.89 91.59 180.62 -- 172.74
Cash Conversion Cycle arrow
-89.93 71.65 -92.70 -- 24.66
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...